— The pharmaceutical company soared more than 10% after Cantor Fitzgerald reiterated an overweight rating on the stock. The firm said it sees sales of TG Therapeutics' treatment for relapsing forms of multiple sclerosis, Briumvi, to come in above expectations for the second quarter.
المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Levi Strauss shares tumble on outlook cut, Mallinckrodt and Alibaba shares rise and more stocks on the moveMallinckrodt, Levi Strauss, Alibaba, Costco and EV makers Nikola and XPeng were all on the move ahead of Friday's market open.
اقرأ أكثر »